Stocks Clock Fourth...
Health Care: Drugs
Johnson & Johnson (JNJ: NYSE)
$88.09 0.64 | 0.73%
05/17/13 - 04:02 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 88.09 |
| 52 Week High | 88.20 |
| 52 Week Low | 61.71 |
| Avg. Daily Vol. (Mil) | 9.72 |
| Beta (3 year) | 0.48 |
| Share Related Items | |
| Mkt Cap (Mil) | 247,434.85 |
| Shares Out (Mil) | 2,808.89 |
| Float (Mil) | 2,790.66 |
| Dividend Information | |
| Yield % | 3.00 |
| Annual Dividend | 2.64 |
| Payout Ratio | 66.00 |
| Financial Strength | |
| Quick Ratio | 1.50 |
| Current Ratio | 2.10 |
| LT Debt/ Equity | 0.17 |
| Total Debt / Equity | 0.24 |
| Valuation Ratios | |
| Price Earnings | 24.00 |
| Price/Sales | 3.61 |
| Price/Book | 3.70 |
| Price/Cash Flow | 19.60 |
| Per Share Data | |
| Earnings | 3.67 |
| Sales | 24.42 |
| Book Value | 23.80 |
| Cash Flow | 4.49 |
| Business Summary | |
|---|---|
| Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the health care field. | |
| General Information | |
| One Johnson & Johnson Plaza
New Brunswick, NJ 08933 |
|
| www.jnj.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 127600 | |
| CEO: Alex Gorsky | |
| Short Interest | |
| Current Month (Mil) | 82.86 |
| Previous Month (Mil) | 89.45 |
| Short Interest Ratio (Days) | 8.30 |
| Management Effectiveness | |
| Return on Equity | 13.00 |
| Return on Assets | 7.20 |
| Return on Investments | 11.10 |
| Profitability | |
| Gross Margin | 73.20 |
| EBIT Margin | 19.70 |
| Profit Margin | 12.70 |
Portfolios with JNJ
- Portfolio NameUser Type
- UserSlip's Portfolio
- Userralphd5-12
- ContributorStocks Fund Managers Love Q...
- ProGeorge Soros
- ContributorGame of Thrones Portfolio
- UserCapt Jer
- ContributorRocket Stocks for the Week ...
- ContributorShort Squeezes for the Week...
- UserQuicksilver55
- Userlennyvb Portfolio 1
Latest JNJ Headlines from TheStreet
- An Investor's Choice: J&J or Baxter International? 04.19.13 | 06:04 am
- Cramer's 'Mad Money' Recap: Haves and Have-Nots 04.17.13 | 08:04 pm
- 3 Stocks Advancing The Health Care Sector 04.17.13 | 01:04 pm
- Cramer's 6 Stocks in 60 Seconds: ESRX URI BBBY JNJ WDAY TGT 04.17.13 | 12:04 pm
- 5 Stocks Fund Managers Love for 2013 04.17.13 | 11:04 am
- Dow Today: Johnson & Johnson (JNJ) Leads The Day Higher, Bank Of America Corporation (BAC) Lags 04.17.13 | 10:04 am
- Google Offers Next Key Earnings Report 04.17.13 | 08:04 am
- Cramer's Top Stock Picks: KO JNJ GLD HK 04.17.13 | 06:04 am
- Dow Today: Johnson & Johnson (JNJ) Higher 04.16.13 | 11:04 am
- Morning Briefing: 10 Things You Should Know 04.16.13 | 08:04 am
Press Releases for JNJ
- Janssen And Johnson & Johnson To Provide Webcast Presentation Of Simeprevir Phase 3 Clinical Data Presented At The International Liver Congress Of The European Association For The Study Of The Liver (EASL) - PR Newswire 05.02.13 | 05:05 pm
- Johnson & Johnson Announces Dividend Increase Of 8.2% - PR Newswire 04.25.13 | 10:04 am
- Johnson & Johnson To Host Pharmaceuticals Business Review - PR Newswire 04.23.13 | 10:04 am
- Johnson & Johnson Announces Sale Of Elan American Depositary Shares To Elan - PR Newswire 04.18.13 | 09:04 am
- Johnson & Johnson To Webcast Annual Meeting Of Shareholders - PR Newswire 04.11.13 | 07:04 am
- Look And Feel Great This Spring, Despite Allergy Symptoms - PR Newswire 04.09.13 | 07:04 am
- Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles For Recoupment Policies Covering Major Compliance Failures - PR Newswire 04.04.13 | 08:04 am
- Johnson & Johnson To Host Analyst Conference Call On First-Quarter Results - PR Newswire 03.19.13 | 10:03 am
- Cordis Acquires Flexible Stenting Solutions, Inc. - Business Wire 03.12.13 | 09:03 am
- Johnson & Johnson Comments On Venezuelan Currency Devaluation - PR Newswire 02.25.13 | 07:02 am
Partner Headlines for JNJ
- Companies slide $181B through tax loopholes - MSN Money 04.19.13 | 10:04 am
- Protect Yourself From Gold - Seeking Alpha 04.19.13 | 08:04 am
- Market Close Report: NASDAQ Composite index closes at 3,204.67 down -59.96 points - NASDAQ 04.17.13 | 08:04 pm
- Abbott Labs' Q1 Earnings Steady After AbbVie Spinoff - Investor's Business Daily 04.17.13 | 04:04 pm
- Questcor Pharmaceuticals, Inc. (QCOR) Ex-Dividend Date Scheduled for April 18, 2013 - NASDAQ 04.17.13 | 01:04 pm
- Dow up 158 as stocks stage a 'never-mind' rally - MSN Money 04.17.13 | 11:04 am
- The Dip's Been Bought, Now Prepare Or Despair - Seeking Alpha 04.17.13 | 09:04 am
- US corporate earnings boost Wall St - Financial Times 04.16.13 | 09:04 pm
- Biotech Alkermes Poised To Swell On Pipeline Wins - Investor's Business Daily 04.16.13 | 05:04 pm
- J&J Q1 Earnings Beat; Pharma Strong, Devices Weak - Investor's Business Daily 04.16.13 | 04:04 pm
